Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) FCF Margin (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed FCF Margin for 3 consecutive years, with 715.0% as the latest value for Q1 2022.

  • Quarterly FCF Margin fell 53484.0% to 715.0% in Q1 2022 from the year-ago period, while the trailing twelve-month figure was 2380.9% through Dec 2022, down 203852.0% year-over-year, with the annual reading at 2380.9% for FY2022, 203852.0% down from the prior year.
  • FCF Margin for Q1 2022 was 715.0% at SELLAS Life Sciences, down from 257.79% in the prior quarter.
  • The five-year high for FCF Margin was 180.21% in Q4 2020, with the low at 715.0% in Q1 2022.
  • Average FCF Margin over 3 years is 243.18%, with a median of 218.97% recorded in 2021.
  • Peak annual rise in FCF Margin hit -53484bps in 2022, while the deepest fall reached -53484bps in 2022.
  • Over 3 years, FCF Margin stood at 180.21% in 2020, then tumbled by -243bps to 257.79% in 2021, then plummeted by -177bps to 715.0% in 2022.
  • According to Business Quant data, FCF Margin over the past three periods came in at 715.0%, 257.79%, and 180.16% for Q1 2022, Q2 2021, and Q1 2021 respectively.